Cargando…

Editorial: Novel signaling pathways and therapy in breast cancer

Detalles Bibliográficos
Autores principales:	Katsuta, Eriko, Opyrchal, Mateusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227551/ https://www.ncbi.nlm.nih.gov/pubmed/37260979 http://dx.doi.org/10.3389/fonc.2023.1215023

Ejemplares similares

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2021)

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

A Case of Metaplastic Breast Cancer with Prolonged Response to Single Agent Liposomal Doxorubicin
por: Hamad, Lamya, et al.
Publicado: (2016)

Mechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2022)

Editorial: Exploring cancer stem cells signaling pathways
por: Mekapogu, Alpha R., et al.
Publicado: (2023)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2021)

Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer
por: Patergnani, Simone, et al.
Publicado: (2022)

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers
por: Ayoub, Nehad M.
Publicado: (2021)

Editorial: Cancer stem cells as attractive targets for breast cancer therapy
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2023)

Editorial: Exercise, physical therapy, and wellbeing in breast cancer patients
por: de la Torre-Montero, Julio C., et al.
Publicado: (2023)

Editorial: The notch signaling pathway in lymphoid malignancies
por: Fais, Franco, et al.
Publicado: (2023)

Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy
por: Qin, Xian-Yang, et al.
Publicado: (2023)

Editorial: Reviews in breast cancer
por: De Miglio, Maria Rosaria, et al.
Publicado: (2023)

Editorial: Methods in breast cancer
por: Franceschini, Gianluca
Publicado: (2023)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

The Signaling Pathways Associated With Breast Cancer Bone Metastasis
por: Song, Xuelian, et al.
Publicado: (2022)

Editorial: The role of STAT3 signaling pathway in tumor progression
por: Chang, Nan-Shan, et al.
Publicado: (2023)

Editorial: Women in breast cancer: 2021
por: Provenzano, Elena, et al.
Publicado: (2023)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: Impact of Breast MRI on Breast Cancer Treatment and Prognosis
por: Bitencourt, Almir, et al.
Publicado: (2022)

Editorial: New Roles of Autophagy Pathways in Cancer
por: Martins, Waleska K., et al.
Publicado: (2021)

Editorial: New Approaches to Breast Cancer Radiotherapy
por: Jacobson, Geraldine Meerbott, et al.
Publicado: (2021)

Editorial: Non-Coding RNAs in Breast Cancer
por: Zhang, Wenwen, et al.
Publicado: (2021)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
por: Harry, Jordan A., et al.
Publicado: (2021)

The relationship between the Hippo signaling pathway and bone metastasis of breast cancer
por: Han, Qinyu, et al.
Publicado: (2023)

Editorial: Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression
por: Link, Wolfgang, et al.
Publicado: (2021)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Editorial: Treatment for advanced breast cancer with brain metastases
por: Yan, Min, et al.
Publicado: (2023)

Editorial: Quality of Life in Breast Cancer Patients and Survivors
por: Invernizzi, Marco, et al.
Publicado: (2020)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Tolba, Mai F., et al.
Publicado: (2021)

Editorial: Molecular mechanisms in breast cancer progression and metastasis
por: Fedele, Monica, et al.
Publicado: (2022)

Editorial: Update of Current Evidences in Breast Cancer Surgery
por: Franceschini, Gianluca, et al.
Publicado: (2022)

Editorial: Risks and Benefits of Adjuvants to Cancer Therapies
por: Dong, Peixin, et al.
Publicado: (2022)

Editorial: Molecular influences in therapies in ovarian cancer
por: Restaino, Stefano, et al.
Publicado: (2022)

Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression?
por: Sharma, Samantha, et al.
Publicado: (2022)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses
por: López-Urrutia, Eduardo, et al.
Publicado: (2021)

Editorial: Exploring the breast tumor microenvironment: Association to metastasis, novel risk factors and novel treatments and immunotherapies
por: Nava-Castro, Karen Elizabeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_air8jlggh33repud0ldpfcne59